OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer
Chenming Zou, Yuepeng Tang, Ping Zeng, et al.
Nanoscale Horizons (2023) Vol. 8, Iss. 7, pp. 870-886
Closed Access | Times Cited: 9

Showing 9 citing articles:

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131

The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts
Qiu Huang, Yue Ge, Yu He, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3333-3365
Open Access | Times Cited: 7

Invasive metastatic tumor-camouflaged ROS responsive nanosystem for targeting therapeutic brain injury after cardiac arrest
Yiyang Xia, Chenming Zou, Weichao Kang, et al.
Biomaterials (2024) Vol. 311, pp. 122678-122678
Open Access | Times Cited: 2

Unforeseen consequences of synergizing PEGylated rapamycin and quercetin in angiogenesis and metastasis inhibition: Turning failure into benefit
Majdi Al Amili, Chenming Zou, Y. X. Xia, et al.
Chemical Engineering Journal (2023) Vol. 470, pp. 144155-144155
Closed Access | Times Cited: 6

Synergistic effects of multidrug/material combination deliver system for anti-mutidrug-resistant tumor
Fangyuan Guo, Yunlong Jiao, Wenqin Ding, et al.
International Journal of Pharmaceutics (2023) Vol. 649, pp. 123669-123669
Closed Access | Times Cited: 6

Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer
Caroline Linde, Yu-Ting Chien, Zhiqian Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1

Light-Assisted “Nano-Neutrophils” with High Drug Loading for Targeted Cancer Therapy
Daopeng Fan, Shuqi Wang, Ran Huang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 6487-6502
Open Access | Times Cited: 3

Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access

Tumor-associated inflammation: the role and research progress in tumor therapy
Jingxia Xu, Xiaoman Xu, Huiwen Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 102, pp. 106376-106376
Closed Access

Page 1

Scroll to top